Platelet GSK3B activity in patients with late-life depression: Marker of depressive episode severity and cognitive impairment?

References

• Barbosa NR, Junqueira RM, Vallada HP, Gattaz WF. 2007. Association between BanI genotype and increased phospholipase A2 activity in schizophrenia. Eur Arch Psychiatry Clin Neurosci 257:340–343.
   PubMedGoogle Scholar
• Barry FA, Graham GJ, Fry MJ, Gibbins JM. 2003. Regulation of glycogen synthase kinase 3 in humans platelets: a possible role in platelet function? FEBS Lett 553:173–178.
   PubMed Web of Science ®Google Scholar
• Beaulieu JM, Zhang X, Rodriguiz RM, Sotnikova TD, Cools MJ, Wetsel WC, . 2008. Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency. Proc Natl Acad Sci USA 105:1333–1338.
   PubMed Web of Science ®Google Scholar
• Diagnostic and Statistical Manual of Mental Disorder, 4th Text Revision. 2000. American Psychiatric Publishing, Inc. Arlington, USA.
   Google Scholar
• Diniz BS, Nunes PV, Yassuda MS, Pereira FS, Flaks MK, Viola LF, . 2008. Mild cognitive impairment: Cognitive screening or neuropsychological assessment? Rev Bras Psiquiatr 30:316–321.
   PubMedGoogle Scholar
• Diniz B, Teixeira A, Talib L, Mendonça V, Gattaz W, Forlenza OV. 2010a. Serum brain-derived neurotrophic factor level is reduced in antidepressant-free patients with late-life depression. World J Biol Psychiatry 11:550–555.
   PubMed Web of Science ®Google Scholar
• Diniz BS, Teixeira AL, Talib L, Gattaz WF, Forlenza OV. 2010b. Interleukin-1beta serum levels is increased in antidepressant-free elderly depressed patients. Am J Geriatr Psychiatry 18: 172–176.
   PubMedGoogle Scholar
• Diniz BS, Teixeira AL, Talib LL, Mendonça VA, Gattaz WF, Forlenza OV. 2010c. Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression. J Psychiatr Res 44:917–920.
   PubMedGoogle Scholar
• Embi N, Rylatt DB, Cohen P. 1979. Glycogen synthase kinase-2 and phosphorylase kinase are the same enzyme. Eur J Biochem 100:339–47.
   PubMedGoogle Scholar
• First, MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P) New York: Biometrics Research, New York State Psychiatric Institute, 2002.
   Google Scholar
• Folstein MF, Folstein SE, McHugh PR. 1975. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198.
   PubMed Web of Science ®Google Scholar
• Forlenza OV, Torres CA, Talib LL, de Paula VJ, Joaquim HP, Diniz BS, Gattaz WF. 2011. Increased platelet gsk3b activity in patients with mild cognitive impairment and alzheimer's disease. J Psychiatr Res 45:220–4.
   PubMed Web of Science ®Google Scholar
• Forlenza OV, Diniz BS, Talib LL, Radanovic M, Yassuda MS, Ojopi EB, Gattaz WF. 2010. Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment. Rev Bras Psiquiatr 32:216–222.
   PubMedGoogle Scholar
• Gattaz WF, Forlenza OV, Talib LL, Barbosa NR, Bottino CM. 2004. Platelet phospholipase A(2) activity in Alzheimer's disease and mild cognitive impairment. J Neural Transm 111:591–601.
   PubMedGoogle Scholar
• Gould TD, Einat H, Bhat R, Manji HK. 2004. AR-a014418, a selective gsk-3 inhibitor, produces antidepressant-like effects in the forced swim test. Int J Neuropsychopharmacol 7:387–390.
   PubMed Web of Science ®Google Scholar
• Grimes CA, Jope RS. 2001. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol 65:391–426.
   PubMed Web of Science ®Google Scholar
• Hamilton M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62.
   PubMed Web of Science ®Google Scholar
• Hirashima Y, Tsuruzoe K, Kodama S, Igata M, Toyonaga T, Ueki K, . 2003. Insulin down-regulates insulin receptor substrate-2 expression through the phosphatidylinositol 3-kinase/akt pathway. J Endocrinol 179:253–66.
   PubMedGoogle Scholar
• Hye A, Kerr F, Archer N, Foy C, Poppe M, Brown R, . 2005. Glycogen synthase kinase-3 is increased in white cells early in alzheimer's disease. Neurosci Lett 373:1–4.
   PubMed Web of Science ®Google Scholar
• Jope RS, Johnson GV. 2004. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 29:95–102.
   PubMed Web of Science ®Google Scholar
• Jope RS, Roh MS. 2006. Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Curr Drug Targets 7:1421–1434.
   PubMed Web of Science ®Google Scholar
• Jope RS, Yuskaitis CJ, Beurel E. 2007. Glycogen synthase kinase-3 (GSK3): Inflammation, diseases, and therapeutics. Neurochem Res 32:577–595.
   PubMed Web of Science ®Google Scholar
• Kaidanovich-Beilin O, Milman A, Weizman A, Pick CG, Eldar-Finkelman H. 2004. Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus. Biol Psychiatry 55: 781–784.
   PubMed Web of Science ®Google Scholar
• Karege F, Perroud N, Burkhardt S, Schwald M, Ballmann E, La Harpe R, Malafosse A. 2007. Alteration in kinase activity but not in protein levels of protein kinase B and glycogen synthase kinase-3beta in ventral prefrontal cortex of depressed suicide victims. Biol Psychiatry 61:240–245.
   PubMed Web of Science ®Google Scholar
• Klein PS, Melton DA. 1996. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 93:8455–8459.
   PubMed Web of Science ®Google Scholar
• Krishnan V, Han MH, Mazei-Robison M, Iniguez SD, Ables JL, Vialou V, . 2008. Akt signaling within the ventral tegmental area regulates cellular and behavioral responses to stressful stimuli. Biol Psychiatry 64:691–700.
   PubMed Web of Science ®Google Scholar
• Kumamaru E, Numakawa T, Adachi N, Yagasaki Y, Izumi A, Niyaz M, . 2008. Glucocorticoid prevents brain-derived neurotrophic factor-mediated maturation of synaptic function in developing hippocampal neurons through reduction in the activity of mitogen-activated protein kinase. Mol Endocrinol 22:546–58.
   PubMed Web of Science ®Google Scholar
• Lauterbach E, Brunner J, Hawellek B, Lewitzka U, Ising M, Bondy B, . 2006. Platelet 5-HT2A receptor binding and tryptophan availability in depression are not associated with recent history of suicide attempts but with personality traits characteristic for suicidal behavior. J Affect Disord 91:57–62.
   PubMedGoogle Scholar
• Li X, Zhu W, Roh MS, Friedman AB, Rosborough K, Jope RS. 2004. In vivo regulation of glycogen synthase kinase-3beta (GSK3-beta) by serotonergic activity in mouse brain. Neuro psychopharmacology 29:1426–1431.
   Google Scholar
• Li X, Friedman AB, Zhu W, Wang L, Boswell S, May RS, Davis LL, Jope RS. 2007a. Lithium regulates glycogen synthase kinase-3beta in human peripheral blood mononuclear cells: Implication in the treatment of bipolar disorder. Biol Psychiatry 61:216–222.
   PubMedGoogle Scholar
• Li X, Rosborough KM, Friedman AB, Zhu W, Roth KA. 2007b. Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics. Int J Neuropsychopharmacol 10:7–19.
   PubMed Web of Science ®Google Scholar
• Mai L, Jope RS, Li X. 2002. BDNF-mediated signal transduction is modulated by gsk3beta and mood stabilizing agents. J Neurochem 82:75–83.
   PubMed Web of Science ®Google Scholar
• Nunes PV, Diniz BS, Radanovic M, Abreu ID, Borelli DT, Yassuda MS, Forlenza OV. 2008. CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a brazilian clinical sample of moderate to high education. Int J Geriatr Psychiatry 23:1127–1133.
   PubMed Web of Science ®Google Scholar
• Pan A, Ye X, Franco OH, Li H, Yu Z, Zou S, . 2008. Insulin resistance and depressive symptoms in middle-aged and elderly chinese: Findings from the nutrition and health of aging population in china study. J Affect Disord 109:75–82.
   PubMedGoogle Scholar
• Pandey GN, Ren X, Rizavi HS, Dwivedi Y. 2010. Glycogen synthase kinase-3beta in the platelets of patients with mood disorders: Effect of treatment. J Psychiatr Res 44: 143–148.
   PubMedGoogle Scholar
• Peineau S, Bradley C, Taghibiglou C, Doherty A, Bortolotto ZA, Wang YT, Collingridge GL. 2008. The role of gsk-3 in synaptic plasticity. British J Pharmacol 153(Suppl 1):S428–437.
   Google Scholar
• Polter A, Beurel E, Yang S, Garner R, Song L, Miller CA, . 2010. Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances. Neuropsychopharmacology 35:1761–1774.
   PubMed Web of Science ®Google Scholar
• Prickaerts J, Moechars D, Cryns K, Lenaerts I, van Craenendonck H, Goris I, . 2006. Transgenic mice overexpressing glycogen synthase kinase 3beta: A putative model of hyperactivity and mania. J Neurosci 26:9022–9029.
   PubMed Web of Science ®Google Scholar
• Roth M, Tym E, Mountjoy CQ, Huppert FA, Hendrie H, Verma S, Goddard R. 1986. Camdex. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 149:698–709.
   PubMed Web of Science ®Google Scholar
• Rylatt DB, Aitken A, Bilham T, Condon GD, Embi N, Cohen P. 1980. Glycogen synthase from rabbit skeletal muscle. Amino acid sequence at the sites phosphorylated by glycogen synthase kinase-3, and extension of the n-terminal sequence containing the site phosphorylated by phosphorylase kinase. Eur J Biochem 107:529–537.
   PubMedGoogle Scholar
• Teixeira AL, Barbosa IG, Diniz BS, Kummer A. 2010. Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function. Biomarker Med 4:871–887.
   PubMed Web of Science ®Google Scholar
• Wang QM, Fiol CJ, DePaoli-Roach AA, Roach PJ. 1994. Glycogen synthase kinase-3 beta is a dual specificity kinase differentially regulated by tyrosine and serine/threonine phosphorylation. J Biol Chem 269:14566–14574.
   PubMed Web of Science ®Google Scholar